Frequency of Hepatic Encephalopathy in Post liver Transplant Patients
Hassan Nadeem, Muhammad Omer Farooq, Niaz Muhammad, Kashif Rafi, Asmat Ullah, Sadia Jabbar
923
ABSTRACT
Objective: The objective of this study was to determine the frequency of hepatic
encephalopathy in post liver transplant patients at a tertiary care hospital in
Punjab.
Study Design: It was a descriptive case series.
Setting: Research was conducted at Department of Gastroenterology, Shaikh Zayed
Hospital Lahore.
Duration: Duration of study was 6 months after the approval of synopsis from
05/08/2017 to 04/02/2018.
Material and Methods: This study involved 139 patients of both genders aged between 30-70
years diagnosed of chronic liver disease and undergoing liver transplantation.
Patients were followed in the post-transplant period and hepatic encephalopathy
was diagnosed using West Haven Criteria ≥Stage I during 4 weeks period after
transplant. A written informed consent was obtained from every patient.
Results: The mean age of the patients was 48.1±8.6 years. Most of the patients
were aged between 51-65 years (59.0%) followed by 35-50 years (41.0%). There
were 90 (64.7%) male and 49 (35.3%) female patients in the study group with a
male to female ratio of 1.8:1. Chronic hepatitis C was the most frequent
underlying cause and was observed in 105 (75.5%) patients followed by chronic
hepatitis B (12.9%) and autoimmune hepatitis (11.6%). Post-transplant hepatic
encephalopathy was diagnosed in 17 (12.2%) patients. 10 (7.2%) patients had
stage-I, 5 (3.6%) patients had stage-II and 2 (1.4%) patients had stage-III
encephalopathy. There was no significant difference in the frequency of
post-transplant hepatic encephalopathy across age (p-value=0.988), gender
(p-value=0.997) and underlying cause (p-value=0.714).
Conclusion: Hepatic encephalopathy was observed in a substantial proportion of
patients undergoing liver transplantation for chronic liver disease which
warrants routine monitoring of such patients in the post-operative period so
that timely identification and management can improve the outcome among such
cases.
Keywords: Chronic Liver Disease, Liver Transplant, Hepatic Encephalopathy
ABSTRACT
Objective: The objective of this study was to determine the frequency of hepatic
encephalopathy in post liver transplant patients at a tertiary care hospital in
Punjab.
Study Design: It was a descriptive case series.
Setting: Research was conducted at Department of Gastroenterology, Shaikh Zayed
Hospital Lahore.
Duration: Duration of study was 6 months after the approval of synopsis from
05/08/2017 to 04/02/2018.
Material and Methods: This study involved 139 patients of both genders aged between 30-70
years diagnosed of chronic liver disease and undergoing liver transplantation.
Patients were followed in the post-transplant period and hepatic encephalopathy
was diagnosed using West Haven Criteria ≥Stage I during 4 weeks period after
transplant. A written informed consent was obtained from every patient.
Results: The mean age of the patients was 48.1±8.6 years. Most of the patients
were aged between 51-65 years (59.0%) followed by 35-50 years (41.0%). There
were 90 (64.7%) male and 49 (35.3%) female patients in the study group with a
male to female ratio of 1.8:1. Chronic hepatitis C was the most frequent
underlying cause and was observed in 105 (75.5%) patients followed by chronic
hepatitis B (12.9%) and autoimmune hepatitis (11.6%). Post-transplant hepatic
encephalopathy was diagnosed in 17 (12.2%) patients. 10 (7.2%) patients had
stage-I, 5 (3.6%) patients had stage-II and 2 (1.4%) patients had stage-III
encephalopathy. There was no significant difference in the frequency of
post-transplant hepatic encephalopathy across age (p-value=0.988), gender
(p-value=0.997) and underlying cause (p-value=0.714).
Conclusion: Hepatic encephalopathy was observed in a substantial proportion of
patients undergoing liver transplantation for chronic liver disease which
warrants routine monitoring of such patients in the post-operative period so
that timely identification and management can improve the outcome among such
cases.
Keywords: Chronic Liver Disease, Liver Transplant, Hepatic Encephalopathy